At the time of writing, Cg Oncology Inc. [CGON] stock is trading at $37.05, down -0.40%. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The CGON shares have gain 6.71% over the last week, with a monthly amount drifted -1.85%, and not seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
Cg Oncology Inc. [NASDAQ: CGON] stock has seen the most recent analyst activity on September 23, 2024, when RBC Capital Mkts initiated its Outperform rating and assigned the stock a price target of $66. Previously, ROTH MKM started tracking the stock with Buy rating on August 28, 2024, and set its price target to $65. On June 28, 2024, BofA Securities initiated with a Buy rating and assigned a price target of $65 on the stock. Morgan Stanley started tracking the stock assigning a Overweight rating and suggested a price target of $55 on February 20, 2024. Goldman initiated its recommendation with a Neutral and recommended $42 as its price target on February 20, 2024. Cantor Fitzgerald started tracking with a Overweight rating for this stock on February 20, 2024, and assigned it a price target of $75. In a note dated February 14, 2024, H.C. Wainwright initiated an Buy rating and provided a target price of $75 on this stock.
For the past year, the stock price of Cg Oncology Inc. fluctuated between $25.77 and $50.23. Currently, Wall Street analysts expect the stock to reach $63.5 within the next 12 months. Cg Oncology Inc. [NASDAQ: CGON] shares were valued at $37.05 at the most recent close of the market. An investor can expect a potential return of 71.39% based on the average CGON price forecast.
Analyzing the CGON fundamentals
Gross Profit Margin for this corporation currently stands at 0.98% with Operating Profit Margin at -125.72%, Pretax Profit Margin comes in at -98.7%, and Net Profit Margin reading is -98.7%. To continue investigating profitability, this company’s Return on Assets is posted at -0.11, Equity is -0.21 and Total Capital is -0.15. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.0.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 36.59 points at the first support level, and at 36.14 for the second support level. However, for the 1st resistance point, the stock is sitting at 37.90, and for the 2nd resistance point, it is at 38.76.
Ratios To Look Out For
It is important to note that Cg Oncology Inc. [NASDAQ:CGON] has a current ratio of 47.57. In addition, the Quick Ratio stands at 47.57 and the Cash Ratio stands at 2.12.
Transactions by insiders
Recent insider trading involved Song Hong Fang, Director, that happened on Aug 29 ’24 when 0.65 million shares were sold. Director, Unique Diamond Investments Ltd completed a deal on Aug 29 ’24 to buy 0.42 million shares. Meanwhile, Director Charming Jade Ltd bought 0.23 million shares on Aug 29 ’24.
